Related Experiment Videos
Gamma-melanotropin and brain function.
Ciba Foundation Symposium
|January 1, 1981
Summary
Gamma-melanocyte-stimulating hormone (gamma-MSH) exhibits distinct behavioral effects opposite to ACTH-like peptides, potentially acting as an opiate antagonist. It attenuates beta-endorphin effects and reduces heroin self-administration.
Area of Science:
- Neuroendocrinology
- Behavioral Neuroscience
- Pharmacology
Background:
- Pro-opiocortin (ACTH/MSH) peptides share structural similarities with gamma-melanocyte-stimulating hormone (gamma-MSH).
- ACTH/MSH-related neuropeptides influence various behavioral processes.
- The behavioral profile of gamma-MSH remains largely unexplored in comparison to related peptides.
Purpose of the Study:
- To investigate the behavioral effects of gamma-MSH.
- To compare the behavioral actions of gamma-MSH with ACTH/MSH-type peptides and opiate modulators.
- To explore the potential interaction of gamma-MSH with the endogenous opioid system.
Main Methods:
- Behavioral testing in rats, focusing on avoidance behavior and grooming.
- Administration of gamma-MSH and related peptides into specific brain regions (periaqueductal gray).
- In vitro assays examining receptor binding (naloxone displacement) and effects on isolated muscle preparations (guinea-pig ileum, rat rectum).
Main Results:
- Gamma-MSH demonstrated opposing effects to ACTH-like peptides on avoidance behavior.
- Gamma-MSH attenuated ACTH(1-24)-induced excessive grooming and elicited opiate withdrawal-like symptoms.
- Gamma-MSH counteracted several beta-endorphin effects, including antinociception and hypothermia, and reduced heroin self-administration acquisition.
Conclusions:
- Gamma-MSH exhibits a unique behavioral profile distinct from ACTH/MSH peptides, resembling opiate antagonists.
- Gamma-MSH may functionally antagonize beta-endorphin effects, possibly via specific gamma-MSH receptors.
- These findings suggest a role for gamma-MSH in modulating opioid-related behaviors and physiological responses.